
Hermine Brunner
Director · Cincinnati Children's Hospital Medical Center
Credentials: · · · ·
History
1997–1999University of Toronto & Cincinnati
- 1987–1991
Ludwig Maximilan University, Munich, Germany
Research
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
New England Journal of Medicine · 2012 · 638 citations
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
New England Journal of Medicine · 2012 · 541 citations
Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
Arthritis & Rheumatism · 2008 · First of 5 authors · 428 citations

80 papers

47 papers

28 papers

25 papers

23 papers

22 papers · 1 as a fellow
- GH
21 papers

21 papers
Grants
- 2022–2027
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $5.3M · Cincinnati Childrens Hosp Med Ctr
- 2019–2025
Pediatric musculOskeletal & RheumaTology Innovation COre Center (PORTICO)
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P30
Contact PI · $3.4M · Cincinnati Childrens Hosp Med Ctr
- 2018–2021
Improving Pediatric Lupus Nephritis Through Personalized Mycophenolate Mofetil Therapy
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R34
Contact PI · $419.8K · Cincinnati Childrens Hosp Med Ctr
- 2014–2018
Optimization of Outcome Measures For Clinical Trials in Children with Lupus
National Institute of Arthritis and Musculoskeletal and Skin Diseases · U01
Contact PI · $611.9K · Cincinnati Childrens Hosp Med Ctr
Clinical trials
- 2024–2027
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Principal investigator · Recruiting · Phase 2
Children's Hospital Medical Center, Cincinnati
- 2017–2023
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus
Principal investigator · Completed · Phase 1, Phase 2
Children's Hospital Medical Center, Cincinnati
- 2003–2014
Triptorelin for Ovary Protection in Childhood Onset Lupus
Principal investigator · Completed · Phase 2
Children's Hospital Medical Center, Cincinnati
- 2026–2028
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Site PI · Recruiting · Phase 1, Phase 2
Cartesian Therapeutics



